Citigroup’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$432 Sell
708
-1,582
-69% -$965 ﹤0.01% 4699
2025
Q1
$1.73K Buy
2,290
+2,048
+846% +$1.55K ﹤0.01% 4565
2024
Q4
$232 Sell
242
-142
-37% -$136 ﹤0.01% 4787
2024
Q3
$553 Sell
384
-7,515
-95% -$10.8K ﹤0.01% 4649
2024
Q2
$9.56K Sell
7,899
-2,944
-27% -$3.56K ﹤0.01% 4406
2024
Q1
$25.5K Buy
10,843
+5,366
+98% +$12.6K ﹤0.01% 4207
2023
Q4
$10.4K Buy
5,477
+4,688
+594% +$8.86K ﹤0.01% 4426
2023
Q3
$1.08K Sell
789
-25,559
-97% -$35K ﹤0.01% 4326
2023
Q2
$64K Buy
26,348
+25,377
+2,613% +$61.7K ﹤0.01% 3828
2023
Q1
$5.59K Sell
971
-79,069
-99% -$455K ﹤0.01% 4231
2022
Q4
$716K Sell
80,040
-40,067
-33% -$358K ﹤0.01% 2293
2022
Q3
$1.71M Buy
120,107
+116,976
+3,736% +$1.66M ﹤0.01% 1713
2022
Q2
$46K Buy
3,131
+1,181
+61% +$17.4K ﹤0.01% 3887
2022
Q1
$39K Sell
1,950
-4,341
-69% -$86.8K ﹤0.01% 4120
2021
Q4
$110K Buy
6,291
+2,048
+48% +$35.8K ﹤0.01% 3919
2021
Q3
$33K Buy
4,243
+1,320
+45% +$10.3K ﹤0.01% 4228
2021
Q2
$30K Sell
2,923
-8,765
-75% -$90K ﹤0.01% 4399
2021
Q1
$153K Buy
11,688
+103
+0.9% +$1.35K ﹤0.01% 3503
2020
Q4
$163K Buy
11,585
+11,280
+3,698% +$159K ﹤0.01% 3360
2020
Q3
$4K Sell
305
-12
-4% -$157 ﹤0.01% 4725
2020
Q2
$5K Sell
317
-604
-66% -$9.53K ﹤0.01% 4803
2020
Q1
$7K Buy
921
+77
+9% +$585 ﹤0.01% 4710
2019
Q4
$9K Buy
844
+649
+333% +$6.92K ﹤0.01% 4732
2019
Q3
$12K Sell
195
-473
-71% -$29.1K ﹤0.01% 4483
2019
Q2
$48K Buy
668
+332
+99% +$23.9K ﹤0.01% 4122
2019
Q1
$16K Buy
336
+121
+56% +$5.76K ﹤0.01% 4596
2018
Q4
$12K Sell
215
-88
-29% -$4.91K ﹤0.01% 4569
2018
Q3
$32K Buy
303
+119
+65% +$12.6K ﹤0.01% 4325
2018
Q2
$12K Sell
184
-12
-6% -$783 ﹤0.01% 4542
2018
Q1
$13K Buy
+196
New +$13K ﹤0.01% 4380